The Regulation of p27Kip1 Expression Following the Polyclonal Activation of Murine G0 T Cells

Journal of Immunology

Volumn 158, Issue 12, 1997, Pages 5642-5648

  Kwon, Taeg Kyu ^a   Buchholz, Meredith A ^a   Ponsalle, Patricia ^a   Chrest, Francis J ^a   Nordin, Albert A ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CDK2 PROTEIN, MOUSE; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIC AMP; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; INTERLEUKIN 2; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; DOWN REGULATION; DRUG ANTAGONISM; GENETIC TRANSFECTION; IMMUNOLOGY; INTERPHASE; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MOUSE; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIC AMP; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DOWN-REGULATION; INTERLEUKIN-2; INTERPHASE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN-SERINE-THREONINE KINASES; T-LYMPHOCYTES; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0031570412     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Pines, J. 1993. Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem. Sci. 18:195.
2. 1 cyclins. Cell 73:1059.
3. 1 phase progression: cycling on cue. Cell 79:551.
4. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131.
5. Roy, R., J. P. Adamczewski, T. Seroz, W. Vermeulen, J. P. Tassan, L. Schaeffer, E. A. Nigg, J. H. J. Hoeimarkers, and J. M. Egly. 1994. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79:93.
6. Feaver, W. J., J. Q. Svejstrup, L. Y. Henry, and R. Kornberg: relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 79:1103.
7. 1-S phase protein kinase. Science 257:1958.
8. 1 phase of the human cell cycle. Science 257:1689.
9. 1 to S phase transition. Mol. Cell. Biol. 15:2612.
10. Hunter, T., and J. Pines. 1994. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79:573.
11. 1 cyclin-dependent kinases. Genes Dev. 9:1149.
12. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M.Trent, D. Lin, E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817.
13. 1 cyclin-dependent kinases. Cell 75:805.
14. Jiang, H., J. Lin, Z. Su, F. R. Collart, E. Huberman, and P. B. Fisher. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397.
15. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9:639.
16. KIP2, a structurally distinct member of the p21 CIP1 cdk inhibitor family, is a candidate minor suppressor gene. Genes Dev. 9:650.
17. Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78:59.
18. 1 cyclin/cdk protein kinase activity, is related to p21. Cell 78:67.
19. Kip1) of cyclin-dependent kinase-4 activation. Cell 79:487.
20. Kip1, cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9.
21. 1 arrest is associated with the induction and accumulation of cyclin-dependent kinase inhibitors. Cell Growth Differ. 7:1305.
22. 1 phase in primary human T lymphocytes. J. Biol. Chem. 268:4113.
23. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077.
24. Lucas, J. J., A. Szepesi, J. F. Modiano, J. Domenico, and E. W. Gelfand. 1995. Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes. J. Immunol. 154:6275.
25. cdk4, during cell cycle entry and progression in normal human T lymphocytes. J. Cell. Physiol. 165:406.
26. Modiano, J. F., J. Domenico, A. Szepesi, J. J. Lucas, and E. W. Gelfand. 1994. Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases cdk4 and cdk2 in human T cells. J. Biol. Chem. 269:32972.
27. Firpo, E. J., A. Koff, M. J. Solomon, and J. M. Roberts. 1994. Inactivation of a cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14:4889.
28. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570.
29. cdc2 kinase activation in T lymphocytes. J. Biol. Chem. 268:22737.
30. 1/S phase growth arrest in T lymphocytes. J. Biol. Chem. 268:3734.
31. Oberdan, L., M. Foo, D. H. Sachs, L. E. Samelson, and J. E. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
32. cdc2 in T lymphocytes. J. Immunol. 149:17.
33. Kwon, T. K., M. A. Buchholz, E. W. Gabrielson, and A. A. Nordin. 1995. A novel cytoplasmic substrate for cdk4 and cdk6 in normal and malignant epithelial derived cells. Oncogene 11:2077.
34. Kip1. Gene 180:113.
35. Poon, R. Y., H. Toyoshima, and T. Hunter. 1995. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with tovastatin or ultraviolet irradiation. Mol. Biol. Cell 6:197.
36. Dumont, F. J., and Q. Su. 1996. Mechanism of action of the immunosuppressant rapamycin. Life Sci. 58:373.
37. Bierer, B. E., G. Hollander, D. Fruman, and S. J. Burakoff. 1993. Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr. Biol. 5:763.
38. Calvo, V., C. M. Crews, T. A. Vik, and B. E. Bierer. 1992. Interleukin-2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc. Natl. Acad. Sci. USA 89:7571.
39. Kuo, C. J., J. Chung, D. F. Fiorentino, W. M. Flanagan, J. Blenis, and G. R. Crabtree. 1992, Inhibition of IL-2 induced p70 S6 kinase activity by the immunosuppressive agent rapamycin. Nature 358:70.
40. Krause, D. S., and C. Deutsch. 1991. Cyclic AMP directly inhibits IL-2 receptor expression in human T cells. J. Immunol. 146:2285.
41. Feuerstein, N., D. Huang, S. H. Hinrichs, D. J. Orten, N. Aiyar, and M. B. Prystowsky. 1995. Regulation of cAMP-responsive enhancer binding proteins during cell cycle progression in T lymphocytes stimulated by IL-2. J. Immunol. 154:68.
42. Cabrera, M. L., A. G. Santis, E. F. Ruiz, R. Blacher, F. Esch, P. S. Mateos, and F. S. Madrid. 1993. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin super family of signal-transmitting receptors. J. Exp. Med. 178:537.
43. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323.
44. Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. A. Fattaey. 1992. cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337.
45. Pagano, M., S. W. Tam, A. M. Theodorasm P. B. Romerom G. D. Salm V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682.
46. Kip1 accumulation during the cell cycle. Science 271:1861.
47. Tocci, M. J., D. A. Matkovich, K. A. Collier, P. Kwok, F. Dumont, S. Lin, S. Degudicibus, J. J. Siekerka, J. Chin, and N. I. Hutchinson. 1989. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J. Immunol. 143:718.
48. Emmel, E. A., C. L. Verwij, D. B. Durand, K. M. Higgin, E. Lacy, and G. R. Crabtree. 1989. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 246:1617.
49. Dumont, F. J., M. J. Staruch, S. K. Koprak, M. R. Melino, and N. H. Sigal. 1990. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK506 and rapamycin. J. Immunol. 144:251.
50. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85707.
51. Kip1. Cell 85:721.
52. Kip1-deficient mice. Cell 85:733.
53. 1. Proc. Natl. Acad. Sci. USA 85:6072.
54. Novak, T. J., and E. V. Rothenberg. 1990. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA 87:9353.